ethyl 1-(2-methoxyphenyl)-1H-imidazole-5-carboxylate | 282107-75-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: ethyl 1-(2-methoxyphenyl)-1H-imidazole-5-carboxylate
• 英文别名: Ethyl 3-(2-methoxyphenyl)imidazole-4-carboxylate
• CAS: 282107-75-9
• 化学式: C₁₃H₁₄N₂O₃
• 分子量: 246.266
• InChiKey: UBSCWIBRICTTSW-UHFFFAOYSA-N

物化性质

• 沸点：
  407.2±25.0 °C(Predicted)
• 密度：
  1.17±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  53.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  ethyl 1-(2-methoxyphenyl)-1H-imidazole-5-carboxylate 在 lithium aluminium tetrahydride 、 戴斯-马丁氧化剂 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 4.0h， 生成 3-(o-methoxy-phenyl)-3H-imidazole-4-carboxaldehyde
  参考文献：
  名称：

  一系列 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles 作为吲哚胺 2,3-Dioxygenase 1 (IDO1) 抑制剂

  摘要：

  吲哚胺 2,3-双加氧酶 1 (IDO1) 是癌症免疫治疗和神经系统疾病的一个有前途的治疗靶点。因此，寻找用于人类癌症的高活性抑制剂现在是广泛研究和开发工作的重点。在这项研究中，我们报告了 2-(5-咪唑基) 吲哚衍生物的基于结构的设计，这是一系列新型 IDO1 抑制剂，这些抑制剂是根据我们之前使用N 1 取代的 5-吲哚咪唑的研究设计和合成的。其中，我们已鉴定出一种具有强 IDO1 抑制活性（IC 50 =0.16 μM，EC 50= 0.3 微米）。结构-活性关系 (SAR) 和计算对接模拟表明，羟基与 Pocket A 中的近端 Ser167 残基有良好的相互作用，从而提高了 IDO1 抑制效力。通过计算血脑屏障 (BBB) 分数和脑暴露效率 (BEE) 分数来估计有效化合物的脑外显率。许多化合物具有良好的得分，两种最有希望的化合物被推进到药代动力学研究，证明这两种化合物都具有脑渗透性。因此，我们发现了一种用于脑渗透

  DOI：

  10.1002/cmdc.202100107
• 作为产物：
  描述：

  ethyl 2-mercapto-3-(2-methoxyphenyl)-3H-imidazole-4-carboxylate 在 硝酸 、 sodium nitrite 作用下， 反应 0.17h， 以86%的产率得到ethyl 1-(2-methoxyphenyl)-1H-imidazole-5-carboxylate
  参考文献：
  名称：

  Syntheses and pKa determination of 1-(o-hydroxyphenyl)imidazole carboxylic esters

  摘要：

  通过其甲醚前体，选择性合成了1-(邻羟基苯基)咪唑羧酸酯的全部三种异构体(1–3)。甲基1-(邻甲氧基苯基)咪唑-2-羧酸酯(6)及其对应的1,4-异构体(11)分别通过铜催化的2-碘苯甲醚与咪唑的偶联反应后进行甲氧羰基化，以及直接将2-碘苯甲醚与甲基咪唑-4-羧酸酯(7)偶联来合成。1,5-异构体(15)通过N-芳基甘氨酸酯衍生物(13)的环合反应制备。通过三溴化硼介导的甲醚断裂反应，以良好至优良的收率得到了羟基苯基化合物(1–3)。这些化合物可作为合成新一代细胞色素c氧化酶(CcO)活性部位模型化合物的构建模块。为了为理解CcO中的质子转移过程提供基础，通过分光光度法测量确定了pKa值。

  DOI：

  10.1039/b000119h

文献信息

• Syntheses and pKa determination of 1-(o-hydroxyphenyl)imidazole carboxylic esters
  作者：James P. Collman、Zhong Wang、Min Zhong、Li Zeng

  DOI：10.1039/b000119h

  日期：——

  All three isomers of 1-(o-hydroxyphenyl)imidazole carboxylic esters (1–3) have been synthesized regioselectively via their methyl ether precursors. Methyl 1-(o-methoxyphenyl)imidazole-2-carboxylate (6) and the corresponding 1,4-isomer (11) were synthesized via Cu-catalyzed coupling of 2-iodoanisole with imidazole followed by methoxycarbonylation, and by direct coupling of 2-iodoanisole with methyl imidazole-4-carboxylate (7), respectively. The 1,5-isomer (15) was prepared by annulation of an N-aryl glycine ester derivative (13). The boron tribromide mediated cleavage of methyl ethers gave the hydroxyphenyl compounds (1–3) in good to excellent yields. These compounds can serve as building blocks for synthesizing a new generation of active-site model compounds of cytochrome c oxidase (CcO). The pKa values have been determined by spectrophotometric measurements in order to provide a basis for the understanding of the proton transfer processes in CcO.

  通过其甲醚前体，选择性合成了1-(邻羟基苯基)咪唑羧酸酯的全部三种异构体(1–3)。甲基1-(邻甲氧基苯基)咪唑-2-羧酸酯(6)及其对应的1,4-异构体(11)分别通过铜催化的2-碘苯甲醚与咪唑的偶联反应后进行甲氧羰基化，以及直接将2-碘苯甲醚与甲基咪唑-4-羧酸酯(7)偶联来合成。1,5-异构体(15)通过N-芳基甘氨酸酯衍生物(13)的环合反应制备。通过三溴化硼介导的甲醚断裂反应，以良好至优良的收率得到了羟基苯基化合物(1–3)。这些化合物可作为合成新一代细胞色素c氧化酶(CcO)活性部位模型化合物的构建模块。为了为理解CcO中的质子转移过程提供基础，通过分光光度法测量确定了pKa值。
• Synthesis of Nitric Oxide Reductase Active Site Models Bearing Key Components at Both Distal and Proximal Sites
  作者：James P. Collman、Ying Yang、Richard A. Decréau

  DOI：10.1021/ol071007p

  日期：2007.7.1

  Porphyrins 1ab and 2ab were successfully synthesized from cis-alpha2-bisimidazole-beta-imidazole-tail porphyrins and two newly synthesized imidazole pickets containing an aliphatic ester chain following a [2+1] approach. The four compounds possess a distal trisimidazole set, a distal carboxylic acid, and a proximal imidazole, which constitute all the key features of the coordination environment of

  按照[2 + 1]方法成功地从顺-α2-双咪唑-β-咪唑-尾卟啉和两个新合成的含脂族酯链的咪唑基中成功合成了卟啉1ab和2ab。这四种化合物具有远端三咪唑组，远端羧酸和近端咪唑，它们构成细菌一氧化氮还原酶（NOR）活性位点配位环境的所有关键特征，并使它们成为最接近的合成NOR模型配体迄今为止。
• [EN] NOVEL THIADIAZOLYL DERIVATIVES OF DNA POLYMERASE THETA INHIBITORS<br/>[FR] NOUVEAUX DÉRIVÉS DU TYPE THIADIAZOLYLE D'INHIBITEURS DE L'ADN POLYMÉRASE THÊTA
  申请人：[en]BEIJING DANATLAS PHARMACEUTICAL CO., LTD.

  公开号：WO2023060573A1

  公开（公告）日：2023-04-20

  Poly theta inhibitor (I), X is -N-or -C-; ring A is phenyl or a five to ten membered heteroaryl ring containing, inclusive of X, one to four heteroatoms independently selected from nitrogen, oxygen, or sulfur, Ar1 is phenyl, heteroaryl, heterocyclyl, bicyclic heterocyclyl, bridged heterocyclyl, or spiroheterocyclyl, wherein each of the aforementioned ring is substituted with Ra, Rb, and/or Rc,wherein Ra and Rb are independently selected from hydrogen, alkyl, halo, haloalkyl, alkoxy, haloalkoxy, cycloalkyloxy, acyl, acylamino, monoalkylamino, dialkylamino, alkylsulfonyl,cyano, and hydroxy; or Ra and Rb, when on adjacent ring vertices, combine to form a C3-6 cycloalkyl, or Ra and Rb, when on the same ring vertex, combine to form oxo, and Rc is selected from hydrogen, alkyl, halo, haloalkyl, alkoxy, haloalkoxy, hydroxy, hydroxyalkyl, alkoxyalkyl, aminoalkyl, heterocyclylalkyl, heterocyclyloxy, aminocarbonyl; Ar2 is phenyl, heteroaryl, or cycloalkyl, wherein said phenyl and heteroaryl are substituted with Rd, Re and/or Rf, wherein Rd and Re are independently selected from hydrogen, alkyl, halo, haloalkyl, alkoxy, haloalkoxy, hydroxy, and cyano and Rf is selected from hydrogen, alkyl, cycloalkyl, halo, haloalkyl, alkoxy, haloalkoxy, hydroxy, cyano, cyanomethyl, aminocarbonylmethyl, heteroaryl, and heterocyclyl, wherein said heteroaryl and heterocyclyl of Rf are unsubstituted or substituted with one, two, or three substituents independently selected from alkyl, halo, haloalkyl, and hydroxy; R1 is hydrogen, alkyl, halo, haloalkyl, haloalkoxy, alkoxy, hydroxy, cyano, cyanoalkyl,carboxy, alkoxycarbonyl, acylamino, aminocarbonyl optionally substituted heteroaryl, hydroxyalkyl, cycloalkyl, hydroxyalkynyl, alkoxyalkyl, aminoalkyl, aminocarbonylalkyl,sulfonylalkyl, aminosulfonylalkyl, optionally substituted heteroaralkyl, or optionally substituted heterocyclylalkyl; and R2 is hydrogen, alkyl, halo, haloalkyl, haloalkoxy, or cyano; Y is O or S or NH or NRg, Rg is a C1 to C3 aliphatic group; R3 and R4 are H, C1-6 aliphatic group.
• A Series of 2‐((1‐Phenyl‐1H‐imidazol‐5‐yl)methyl)‐1H‐indoles as Indoleamine 2,3‐Dioxygenase 1 (IDO1) Inhibitors
  作者：Yong Zheng、Paul M. Stafford、Kurt R. Stover、Darapaneni Chandra Mohan、Mayuri Gupta、Eric C. Keske、Paolo Schiavini、Laura Villar、Fan Wu、Alexander Kreft、Kiersten Thomas、Elana Raaphorst、Jagadeesh P. Pasangulapati、Siva R. Alla、Simmi Sharma、Ramana R. Mittapalli、Irina Sagamanova、Shea L. Johnson、Mark A. Reed、Donald F. Weaver

  DOI：10.1002/cmdc.202100107

  日期：2021.7.20

  Indoleamine 2,3-dioxygenase 1 (IDO1) is a promising therapeutic target in cancer immunotherapy and neurological disease. Thus, searching for highly active inhibitors for use in human cancers is now a focus of widespread research and development efforts. In this study, we report the structure-based design of 2-(5-imidazolyl)indole derivatives, a series of novel IDO1 inhibitors which have been designed

  吲哚胺 2,3-双加氧酶 1 (IDO1) 是癌症免疫治疗和神经系统疾病的一个有前途的治疗靶点。因此，寻找用于人类癌症的高活性抑制剂现在是广泛研究和开发工作的重点。在这项研究中，我们报告了 2-(5-咪唑基) 吲哚衍生物的基于结构的设计，这是一系列新型 IDO1 抑制剂，这些抑制剂是根据我们之前使用N 1 取代的 5-吲哚咪唑的研究设计和合成的。其中，我们已鉴定出一种具有强 IDO1 抑制活性（IC 50 =0.16 μM，EC 50= 0.3 微米）。结构-活性关系 (SAR) 和计算对接模拟表明，羟基与 Pocket A 中的近端 Ser167 残基有良好的相互作用，从而提高了 IDO1 抑制效力。通过计算血脑屏障 (BBB) 分数和脑暴露效率 (BEE) 分数来估计有效化合物的脑外显率。许多化合物具有良好的得分，两种最有希望的化合物被推进到药代动力学研究，证明这两种化合物都具有脑渗透性。因此，我们发现了一种用于脑渗透
• Synthesis of Cytochrome <i>c</i> Oxidase Models Bearing a Tyr²⁴⁴ Mimic
  作者：James P. Collman、Richard A. Decréau、Chi Zhang

  DOI：10.1021/jo0499625

  日期：2004.5.1

  A close structural analogue of the metal-free cytochrome c oxidase active site has been synthesized. This model has a proximal imidazole tail and three distal imidazole pickets attached to a porphyrin. One distal imidazole is cross-linked to a phenol, mimicking Tyr244. The strategy behind the successful synthesis of this regioisomerically pure model involved discovering the best sequence to introduce

  已合成了无金属的细胞色素C氧化酶活性位点的紧密结构类似物。该模型有一个近端咪唑尾巴和三个附着在卟啉上的远端咪唑尖桩。一种远端咪唑与苯酚交联，模仿了Tyr 244。成功合成该区域异构纯模型的背后策略是发现引入苯酚取代的咪唑并采用氟化取代基的最佳序列。